3Mouton JW, Ambrose PG, Canton R, et al. Conserving antibi- otics for the future:New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective [J]. Drug Resist Updat, 2011,14 ( 2 ) : 107 -117.
4Roberts JA, Lipman J. Tissue distribution of beta-lactam antibi- otics : continuous versus bolus dosing [J]. J Pharm Pract Res, 2009,39 (3) :219-222.
5Nielsen EI, Cars O, Friberg LE. Pharmacokinetic/pharmacody- namic (PK/PD)indices of antibiotics predicted by a semi- mechanistic PKPD model:a step toward model-based dose op- timization[J]. Antimicrob Agents Chemother, 2011,55 ( 10 ) : 4619-4630.
6Lodise TP, Drusano GL. Pharmacokinetics and pharmacody- namics :optimal antimicrobial therapy in the intensive care unit [J]. Crit Care Clin,2011,27(1) :1-18.
